Category: CBD Stocks
Aurora Cannabis and UFC® Launch Clinical Research on Use of Hemp-Derived CBD Products by MMA Athletes
New studies to advance the science on CBD use and athlete health and wellness and to drive product development under…
FDA warns CBD product marketer for touting health claims online
On Monday, the FDA said it sent a warning letter to medical cannabis company Curaleaf for illegally selling unapproved products containing…
FDA Warns Wakefield Marijuana Company For Making CBD Health Claims
WAKEFIELD (AP) — U.S. regulators warned a leading marijuana company for making unproven health claims about CBD, the trendy ingredient…
ISBG Announces Accelerated Restocking Schedule Due to Strong Demand for CBD Inventory
LAS VEGAS, NV, July 24, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISBG) (“ISBG”…
GW Pharma’s Results Could Provide Further Stock Price Boost
GW Pharmaceuticals (NASDAQ:GWPH) is expected to announce its results on August 7. Sales figures for its epidiolex drug for childhood…
Top marijuana company gets FDA warning: Stop making unproven CBD health claims
Carla K. Johnson, Associated Press Published 8:31 p.m. ET July 23, 2019 CLOSE In this Nov. 6, 2017 file photo,…
FDA warns top marijuana company for making CBD health claims
U.S. regulators warned a leading marijuana company for making unproven health claims about CBD, the trendy ingredient that’s turning up…
A CBD Cure for Cancer, Alzheimer’s and Pet Anxiety? FDA Says It’s Bogus.
The FDA has only approved one CBD drug since last year. Most of the CBD products on the market don’t…
Curaleaf shares tumble 8% after FDA sends warning letter over CBD health claims
Shares of cannabis company Curaleaf Holdings Inc. tumbled more than 7% Tuesday and dragged the broader sector lower, after the…
Curaleaf shares tumble 8% after FDA warning letter over CBD health claims
Shares of cannabis company Curaleaf Holdings Inc. tumbled 8% Tuesday and dragged the broader sector lower, after the U.S. Food…
Recent Comments